NuCIT combines hands-on medical imaging experience with technology, software, workflow engineering, and clinical operations — connecting four practice areas under one company.
NuCIT Consulting Corp. is a specialized medical-imaging technology and clinical-operations company based in Miami, Florida, serving clients across North America. We operate at the intersection of medical imaging technology, PACS and DICOM interoperability, imaging workflow consulting, specialized imaging software, nuclear medicine, PET/CT and SPECT/CT, theranostics, radiopharmaceutical operations, and clinical trial imaging.
We are deliberately not a generic IT consulting company, not a generic healthcare SaaS startup, not only a PACS reseller, not only a nuclear medicine consulting company, and not only a clinical research company. NuCIT is the umbrella brand connecting all of these capabilities — able to move from infrastructure design into clinical execution without handing a client off between vendors.
That range is what NuCIT is built around: an imaging infrastructure team that also understands radiopharmaceutical operations; a clinical trial imaging team that also understands PACS and DICOM connectivity; and software — RadioPharma Waste Manager — built from that same operational depth.
Cloud PACS, DICOM viewing, and Vendor-Neutral Archive, deployed as an Authorized Purview Solutions Partner.
NuCIT-owned software managing radioactive waste from intake through disposal and reporting.
Design, troubleshooting, and modernization of medical imaging environments.
Imaging operations for trials involving PET/CT, SPECT/CT, nuclear medicine, and theranostics.
NuCIT understands both the technology and the day-to-day execution of imaging operations — infrastructure and clinical, in the same organization.
From our Miami base, NuCIT teams work directly with imaging departments, research sites, and sponsors throughout North America — combining on-the-ground operational experience with remote infrastructure and consulting support.
Get in Touch →
Whether it's infrastructure, software, or clinical trial imaging — we'd like to hear about it.
